| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 101,290 | 243,501 | 170,259 | 357,310 | | Cost of Revenue | 54,117 | 157,504 | 185,912 | 314,588 | | | Gross Profit | 47,173 | 85,997 | (15,653) | 42,722 | | | Operating Expenses | | Research Development | 19,304 | 22,158 | 25,186 | 27,235 | | Selling General and Administrative | 10,658 | 55,021 | 38,128 | 92,190 | | Non Recurring | 870 | 1,652 | 8,182 | 122,883 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,084) | 7,166 | (87,149) | (199,586) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 59 | (1,519) | 1,946 | | Earnings Before Interest And Taxes | (5,794) | 7,225 | (88,668) | (197,640) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (5,794) | 7,225 | (88,668) | (197,640) | | Income Tax Expense | 154 | 1,000 | 8,366 | (5,780) | | Minority Interest |
-
|
-
| 160 | 106 | | | | Net Income From Continuing Ops | (5,948) | 6,225 | (96,874) | (191,754) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,386) | 6,225 | (96,874) | (191,754) | | Preferred Stock And Other Adjustments | (184) | 184 |
-
|
-
| | | Net Income Applicable To Common Shares | ($5,570) | $6,409 | ($96,874) | ($191,754) |
|
0.11% Nasdaq 0.00%
Income Statement
